|
Code
|
13971
|
|
MA number
|
14/0372/95-S
|
|
Product Form:
|
sus inh 1x120 dávok (nád.tlak.Al)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
National
|
|
MAH, country:
|
GlaxoSmithKline Trading Services Limited, Ireland
|
|
Therapeutic Class:
|
14 - BRONCHODILATANTIA, ANTIASTHMATICA
|
|
ATC:
|
| R |
RESPIRATORY SYSTEM |
| R03 |
DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| R03B |
OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| R03BA |
Glucocorticoids |
| R03BA05 |
Fluticasone |
|
|
Shelf life:
|
24 |
|
Container:
|
pressurised container, aluminium
|
|
Route of admin.:
|
Inhalation use
|
PIL_Flixotide Inhaler N_06/2025.pdf
